FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Smart Insulin Pen Cleared for Android Users

FDA clears a Companion Medical 510(k) for an Android version of its InPen app, clearing the way for release of the first smart pen system for Android ...

Human Drugs

Draft Guide on Cadmium Elemental Impurities Q3D

FDA posts a draft guide from the International Council for Harmonization on cadmium hazards, entitled Elemental Impurities Q3D(R1).

Human Drugs

Hypertension Drugs Draft Guidance

FDA posts a draft guidance entitled Hypertension: Conducting Studies of Drugs to Treat Patients on a Background of Multiple Antihypertensive Drugs.

Federal Register

Draft Guide on Hemophilia Gene Therapy Products

Federal Register notice: FDA makes available a draft guidance entitled Human Gene Therapy for Hemophilia; Draft Guidance for Industry.

Federal Register

Draft Guide on Rare Disease Gene Therapies

Federal Register notice: FDA makes available a draft document entitled Human Gene Therapy for Rare Diseases; Draft Guidance for Industry.

Federal Register

Guide on CMC Info for Gene Therapy Products

Federal Register notice: FDA makes available a draft guidance entitled Chemistry, Manufacturing, and Control Information for Human Gene Therapy Invest...

Medical Devices

FDA Clears Abbotts Next-gen MitraClip Valve Repair

FDA approves Abbotts next-generation MitraClip heart valve repair device used to mend a leaky mitral valve without open-heart surgery.

Human Drugs

Orphan Designation for Accelerons ACE-083

FDA grants Acceleron Pharma an orphan drug designation for ACE-083, the companys locally acting myostatin+ muscle agent, for treating patients with fa...

Human Drugs

AbbVie Files Venetoclax sNDA for Use in AML

AbbVie files a supplemental NDA for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for treating new...

Medical Devices

BioElectronics 510(k) for ActPatch for Musculoskeletal Pain

BioElectronics files a 510(k) for ActiPatch and its over-the-counter adjunctive use in treating musculoskeletal pain.